• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项旨在降低急性脑损伤患者体温以减少全身氧消耗的前瞻性观察性临床试验。

A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.

作者信息

Hata J Steven, Shelsky Constance R, Hindman Bradley J, Smith Thomas C, Simmons Jonathan S, Todd Michael M

机构信息

The Division of Critical Care, Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

出版信息

Neurocrit Care. 2008;9(1):37-44. doi: 10.1007/s12028-007-9015-1.

DOI:10.1007/s12028-007-9015-1
PMID:17985248
Abstract

INTRODUCTION

Fever after acute brain injury appears to be a detrimental factor, associated with impaired neurological outcomes. This study assessed physiological changes in systemic oxygen consumption (VO2) during cutaneous cooling after severe brain injury.

METHODS

This prospective, observational, clinical study evaluated ten, critically ill, brain-injured patients requiring mechanical ventilation with a core body temperature of greater or equal to 38 degrees C. Febrile patients failing to defervesce after acetaminophen underwent indirect calorimetry for a 1-hour baseline period followed by a 4 h cooling period. The Arctic Sun(R) Temperature Management System (Medivance) directed core temperature to a goal of 36 degrees C.

RESULTS

The patients had a mean age of 32 years (95% CI 23, 40), Glasgow Coma Scale of 6 (95% CI 5,7), and APACHE 2 score of 19 (95% CI 15, 22), with 8 of 10 patients suffering traumatic brain injuries. The baseline 1-h core temperature was significantly reduced from 38.6 degrees +/- 0.9 to 36.3 degrees +/- 1.2 degrees C (P < 0.0001) over 4 h. Two cohorts were identified based upon the presence or absence of shivering. Within the non-shivering cohort, systemic VO2 was significantly reduced from 415 +/- 123 to 308 +/- 115 ml/min (-27 +/- 18%) (P < 0.05). In contrast, those with shivering showed no significant reduction in VO2, despite significantly decreasing core temperature. The overall percentage change of VCO2 correlated with VO2 (r (2) = 0.91).

CONCLUSION

Fever reduction in acute brain injury appears to significantly reduce systemic VO2, but is highly dependent on shivering control.

摘要

引言

急性脑损伤后发热似乎是一个有害因素,与神经功能预后受损有关。本研究评估了重度脑损伤后皮肤降温期间全身氧耗量(VO2)的生理变化。

方法

这项前瞻性、观察性临床研究评估了10例需要机械通气、核心体温大于或等于38摄氏度的重症脑损伤患者。对服用对乙酰氨基酚后仍未退热的发热患者进行1小时基线期的间接测热法,随后进行4小时的降温期。北极光温度管理系统(Medivance)将核心温度控制在36摄氏度的目标。

结果

患者的平均年龄为32岁(95%可信区间23,40),格拉斯哥昏迷量表评分为6分(95%可信区间5,7),急性生理与慢性健康状况评分系统II(APACHE 2)评分为19分(95%可信区间15,22),10例患者中有8例患有创伤性脑损伤。在4小时内,基线1小时核心温度从38.6摄氏度±0.9显著降至36.3摄氏度±1.2摄氏度(P<0.0001)。根据是否存在寒战确定了两个队列。在无寒战队列中,全身VO2从415±123显著降至308±115毫升/分钟(-27±18%)(P< .05)。相比之下,有寒战的患者尽管核心温度显著下降,但VO2没有显著降低。VCO2的总体百分比变化与VO2相关(r(2)=0.91)。

结论

急性脑损伤时降低发热似乎能显著降低全身VO2,但高度依赖于对寒战的控制。

相似文献

1
A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.一项旨在降低急性脑损伤患者体温以减少全身氧消耗的前瞻性观察性临床试验。
Neurocrit Care. 2008;9(1):37-44. doi: 10.1007/s12028-007-9015-1.
2
Metabolic Manipulation and Therapeutic Hypothermia.代谢干预与治疗性低温
Ther Hypothermia Temp Manag. 2024 Mar;14(1):46-51. doi: 10.1089/ther.2023.0010. Epub 2023 Jul 3.
3
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.一种用于神经重症监护患者发热控制的新型表面冷却系统的临床试验。
Crit Care Med. 2004 Dec;32(12):2508-15. doi: 10.1097/01.ccm.0000147441.39670.37.
4
Feasibility and Safety of Transnasal High Flow Air to Reduce Core Body Temperature in Febrile Neurocritical Care Patients: A Pilot Study.经鼻高流量空气降低发热神经危重症患者核心体温的可行性和安全性:一项初步研究。
Neurocrit Care. 2019 Oct;31(2):280-287. doi: 10.1007/s12028-019-00702-x.
5
Effect of cooling on oxygen consumption in febrile critically ill patients.降温对发热危重症患者氧消耗的影响。
Am J Respir Crit Care Med. 1995 Jan;151(1):10-4. doi: 10.1164/ajrccm.151.1.7812538.
6
Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale.治疗性体温调节期间寒战的代谢影响:床边寒战评估量表
Stroke. 2008 Dec;39(12):3242-7. doi: 10.1161/STROKEAHA.108.523654. Epub 2008 Oct 16.
7
Comparison of fever treatments in the critically ill: a pilot study.危重症患者发热治疗的比较:一项初步研究。
Am J Crit Care. 2001 Jul;10(4):276-80.
8
Moderate hypothermia improves imbalances of thromboxane A2 and prostaglandin I2 production after traumatic brain injury in humans.中度低温可改善人类创伤性脑损伤后血栓素A2和前列腺素I2生成的失衡。
Crit Care Med. 2000 Dec;28(12):3902-6. doi: 10.1097/00003246-200012000-00029.
9
Acetaminophen has limited antipyretic activity in critically ill patients.对危重症患者,对乙酰氨基酚的解热作用有限。
J Crit Care. 2010 Jun;25(2):363.e1-7. doi: 10.1016/j.jcrc.2009.07.005. Epub 2009 Sep 24.
10
Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury: a randomized controlled trial.严重创伤性脑损伤患者中,长时间轻度治疗性低温与通过严格血流动力学监测及缓慢复温进行发热控制的比较:一项随机对照试验
J Neurotrauma. 2015 Apr 1;32(7):422-9. doi: 10.1089/neu.2013.3197. Epub 2015 Jan 8.

引用本文的文献

1
Clinical Management in Traumatic Brain Injury.创伤性脑损伤的临床管理
Biomedicines. 2024 Apr 2;12(4):781. doi: 10.3390/biomedicines12040781.
2
Minimizing Shivering During Targeted Normothermia: Comparison Between Novel Transnasal and Surface Temperature-Modulating Devices.在目标体温正常化期间尽量减少寒战:新型经鼻和表面温度调节装置的比较。
Neurocrit Care. 2023 Dec;39(3):639-645. doi: 10.1007/s12028-023-01793-3. Epub 2023 Jul 27.
3
Esophageal Cooling Device Versus Other Temperature Modulation Devices for Therapeutic Normothermia in Subarachnoid and Intracranial Hemorrhage.

本文引用的文献

1
Hyperthermia and hypermetabolism in focal cerebral ischemia.局灶性脑缺血中的体温过高与代谢亢进
Adv Exp Med Biol. 2005;566:83-9. doi: 10.1007/0-387-26206-7_12.
2
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.新生儿缺氧缺血性脑病的全身低温治疗
N Engl J Med. 2005 Oct 13;353(15):1574-84. doi: 10.1056/NEJMcps050929.
3
Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation.在一组接受机械通气的患者中使用镇静剂和神经肌肉阻滞剂。
用于蛛网膜下腔出血和颅内出血治疗性体温正常化的食管冷却装置与其他温度调节装置的比较
Ther Hypothermia Temp Manag. 2018 Mar;8(1):53-58. doi: 10.1089/ther.2017.0033. Epub 2017 Dec 13.
4
The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.目标温度管理的实施:神经重症监护学会的循证指南。
Neurocrit Care. 2017 Dec;27(3):468-487. doi: 10.1007/s12028-017-0469-5.
5
Monitoring inflammation (including fever) in acute brain injury.监测急性脑损伤中的炎症(包括发热)。
Neurocrit Care. 2014 Dec;21 Suppl 2:S177-86. doi: 10.1007/s12028-014-0038-0.
6
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.神经重症监护多模态监测国际多学科共识会议共识总结声明:神经重症监护学会和欧洲重症监护医学学会给医疗专业人员的声明
Neurocrit Care. 2014 Dec;21 Suppl 2(Suppl 2):S1-26. doi: 10.1007/s12028-014-0041-5.
7
The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review.神经肌肉阻滞在创伤性脑损伤患者中的作用:一项系统综述。
Neurocrit Care. 2015 Apr;22(2):325-34. doi: 10.1007/s12028-014-0061-1.
8
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.国际神经危重病多模态监测多学科共识会议共识总结声明:来自神经危重病学会和欧洲危重病医学会的医疗保健专业人员的声明。
Intensive Care Med. 2014 Sep;40(9):1189-209. doi: 10.1007/s00134-014-3369-6. Epub 2014 Aug 20.
9
[News and perspectives in neurocritical care].[神经重症监护的新闻与观点]
Nervenarzt. 2014 Aug;85(8):928-38. doi: 10.1007/s00115-014-4040-8.
10
Fever management in SAH.蛛网膜下腔出血的发热管理。
Neurocrit Care. 2011 Sep;15(2):287-94. doi: 10.1007/s12028-011-9588-6.
Chest. 2005 Aug;128(2):496-506. doi: 10.1378/chest.128.2.496.
4
Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.新生儿脑病后选择性头部降温联合轻度全身低温治疗:多中心随机试验
Lancet. 2005;365(9460):663-70. doi: 10.1016/S0140-6736(05)17946-X.
5
Moderate hypothermia in neonatal encephalopathy: efficacy outcomes.新生儿脑病中的中度低温:疗效结果
Pediatr Neurol. 2005 Jan;32(1):11-7. doi: 10.1016/j.pediatrneurol.2004.06.014.
6
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.一种用于神经重症监护患者发热控制的新型表面冷却系统的临床试验。
Crit Care Med. 2004 Dec;32(12):2508-15. doi: 10.1097/01.ccm.0000147441.39670.37.
7
A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest.一项评估心脏骤停后使用CoolGard系统和Icy导管的可行性和安全性的前瞻性、多中心试点研究。
Resuscitation. 2004 Aug;62(2):143-50. doi: 10.1016/j.resuscitation.2004.02.016.
8
Severe traumatic head injury in adults: which patients are at risk of early hyperthermia?成人重型创伤性脑损伤:哪些患者有早期体温过高的风险?
Intensive Care Med. 2004 May;30(5):785-90. doi: 10.1007/s00134-004-2280-y. Epub 2004 Mar 30.
9
Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response.安乃近、丙帕他莫或外部降温退热对代谢、血流动力学及炎症反应影响的随机试验
Intensive Care Med. 2004 Mar;30(3):401-7. doi: 10.1007/s00134-003-2087-2. Epub 2004 Jan 13.
10
Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture.脑缺血病理生理学的探索:半暗带、基因表达、神经保护——2002年托马斯·威利斯讲座
Stroke. 2003 Jan;34(1):214-23. doi: 10.1161/01.str.0000048846.09677.62.